Phospho-ANAPC1 (Ser688) Polyclonal Antibody


  • Specification
  • Target Information
  • Related Products
Cat.No.:  EAb-0057
Product Name:  Phospho-ANAPC1 (Ser688) Polyclonal Antibody
Product Overview:  Polyclonal antibody to detect endogenous levels of ANAPC1 (pS688) in human and mouse.
Antibody Type:  Polyclonal
Immunogen:  KLH-conjugated synthetic peptide encompassing a sequence within the center region of human ANAPC1
Host:  Rabbit
Isotype:  IgG
Antibody Target:  ANAPC1
Purification:  Affinity purified
Appearance:  Colorless liquid
Formulation:  In 0.42% Potassium phosphate; 0.87% Sodium chloride; pH 7.3; 30% glycerol and 0.01% sodium azide
Applications:  WB, IH, IF/IC
Recommended Dilutions/Conditions:  WB; 1:500 – 1:2000, IHC; 1:50 – 1:200, IF/IC; 1:50 – 1:100
Recommended dilutions/conditions may not be available for all applications. Specific conditions for reactivity should be optimized by the end user.
Positive Control:  WB: HEK293; IHC: human breast cancer tissue; IFC: HEK293 cells
Species Reactivity:  Human, Mouse
Shipping:  Gel Pack
Storage:  -20°C
Warning:  For Research Use Only! Not For Use in Humans.
Accession:  Q9H1A4
Alternative Name:  TSG24, Anaphase-promoting complex subunit 1, APC1, Cyclosome subunit 1, Mitotic checkpoint regulator, Testis-specific gene 24 protein
Scientific Background:  Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains.

Online Inquiry

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

USA

Enter your email here to subscribe.

Follow us on

Easy access to products and services you need from our library via powerful searching tools

Copyright © Creative BioMart. All Rights Reserved.